Addressing Tumor Blood Vessels

Nature Biotechnology

Volumn 15, Issue 6, 1997, Pages 510-

  Folkman, Judah ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; FUMAGILLOL CHLOROACETYLCARBAMATE; THROMBOCYTE FACTOR 4;

ANGIOGENESIS; CANCER RESEARCH; DRUG RESEARCH; HUMAN; NONHUMAN; NOTE; PRIORITY JOURNAL; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

APOPTOSIS; ENDOTHELIUM, VASCULAR; HUMANS; MICROCIRCULATION; MODELS, BIOLOGICAL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, VITRONECTIN;

EID: 0031006415     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0697-510     Document Type: Article

References (11)

1. Brooks, P.C. et al. 1994. Cell 79:1157-1164.
2. Pasqualini, R., Koivunen, E., Ruoslahti, E. 1997. Nature Biotechnology 15:542-546.
3. Denekamp, J. 1990. Cancer Metast. Rev. 3:267-282.
4. O’Reilly, M.S. et al. 1997. Cell 88:277-285.
5. Ingter, D.E. 1997. Discovery of TNP-470 and other angiogenesis inhibitors, in Cancer Therapeutics: Experimental and Clinical Agents. Teicher, B. (ed.). Humana Press, Totowa, NJ.
6. Huang, X. et al. 1997. Science 275:547-550.
7. Kerbel, R.S. 1991. BioEssays 13:31-36.
8. Belotti, D. et al. 1996. Clin. Cancer Res. 2:1843-1849.
9. Gasparini, G. 1996. Eur. J. Cancer 32A:2485-2493.
10. Esserman, L., Weidner, N., Yassa, L., HyIron, N. 1996. Prac. Am. Soc. Clin. Oncol. 15:129.
11. Singh, R.K., Gutman, M., Bucana, C.D., Sanchez, R., Ilansa, N., Fidler, I.J. 1995. Prac. Natl. Acad. Sci. USA 92:4562–4566.